InVivo Therapeutics Holdings Corp. - stock earnings
Stock symbol NVIV is outdated, potentially delisted? Maybe it is available on other exchange?
NVIV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -2.4 million USD | ? USD |
| 2022Q3 | -2.8 million USD | ? USD |
| 2022Q2 | -2.7 million USD | ? USD |
| 2022Q1 | -2.7 million USD | ? USD |
| 2021Q4 | -2.9 million USD | ? USD |
| 2021Q3 | -2.5 million USD | ? USD |
| 2021Q2 | -2.3 million USD | ? USD |
| 2021Q1 | -2.2 million USD | ? USD |
| 2020Q4 | -2.2 million USD | ? USD |
| 2020Q3 | -2.3 million USD | ? USD |
NVIV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -10.5 million USD | ? USD |
| 2021 | -9.9 million USD | ? USD |
| 2020 | -9.1 million USD | ? USD |
| 2019 | -11.8 million USD | ? USD |
| 2018 | -23.4 million USD | ? USD |
| 2017 | -26.7 million USD | ? USD |
NVIV
Price: $0.32
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -0.16
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 61700
Ebitda: -9.2 millionMarket Capitalization: 995917